Farallon Capital Management’s Telix Pharmaceuticals TLX Stock Holding History
Bought
Maintained
Sold
Other funds holding TLX
Farallon Capital Management's TLX Position: Q3 2026 in Review
Farallon Capital Management opened a new position in Telix Pharmaceuticals (TLX) in Q3 2026: 419,000 shares worth $4.6M. The stake represents 0.02% of the portfolio and ranks #101 among its holdings.
71 funds tracked by Wall St. Rank hold TLX as of Q3 2026.
- Farallon Capital Management held 419,000 shares of Telix Pharmaceuticals worth $4.6M as of Q3 2026.
- Telix Pharmaceuticals was a new Farallon Capital Management position in Q3 2026.
- Telix Pharmaceuticals made up 0.02% of Farallon Capital Management's portfolio in Q3 2026, its #101 holding.
- 71 funds tracked by Wall St. Rank held Telix Pharmaceuticals as of Q3 2026.
Based on Farallon Capital Management's 13F filing for Q3 2026, filed 16 Nov 2026.